Zydus Wellness Jumps 13% on Motilal Oswal 'Buy' Rating, 80% Upside Potential

• Zydus Wellness shares surged 13% today, December 31, after Motilal Oswal initiated coverage with a 'Buy' rating.
• Motilal Oswal set a base case target of Rs 575 (35% upside) and projected an 80% rise in a bull case scenario.
• The brokerage highlights Zydus Wellness's strong brand portfolio (Sugar Free, Glucon-D, Everyuth) and strategic acquisitions.
• Valuation is attractive, trading at a 30-35% discount to FMCG peers, with strong earnings growth projected (36% consolidated EBITDA CAGR FY25-FY28).
• Risks include seasonal demand, input cost fluctuations, and increasing competition.

Why It Matters: Motilal Oswal's 'Buy' rating and strong growth outlook fueled Zydus Wellness's 13% surge.